Skip to main content
Top
Published in: Supportive Care in Cancer 5/2004

01-05-2004 | Short Communication

Sleep disorders in advanced cancer patients: prevalence and factors associated

Authors: Sebastiano Mercadante, Davide Girelli, Alessandra Casuccio

Published in: Supportive Care in Cancer | Issue 5/2004

Login to get access

Abstract

Goals of work

Sleep disorders have been invariably reported in cancer population. However, the prevalence of this problem in advanced cancer patients has never been assessed. The aim of this study was to evaluate the frequency of sleep disturbances in terms of quantity and quality, and possible associated factors.

Patients and methods

A consecutive sample of patients admitted to a pain relief and palliative care unit were surveyed. Patients with severe cognitive problems or who were too ill were excluded. Epidemiological and clinical data, including the performance status, habits, relevant symptoms, and drug use were recorded. Patients were asked to answer a small questionnaire regarding their sleep, and duration and characteristics (nocturnal and diurnal hours slept, falling asleep, awaking, getting back to sleep, early awaking, restoring sleep, nightmares, feeling depressed or anxious). The level of information about the illness was also assessed.

Main results

Among the causes of admission, pain control was the main indication (about 58%). Of 123 patients surveyed, 30% slept less than 5 h. Women significantly slept more hours than men (p=0.042). Anxiety (p=0.045), falling asleep (p=0.003), awaking (p=0.035), early awaking (p=0.001), getting beck to sleep (p=0.021), and nightmares (p=0.034), were significantly associated with less hours slept. This relationship was highly significant for less restoring sleep, fatigue, and drowsiness (p<0.0005). No differences were found for age (p=0.294), primary tumor (p=0.225), level of information (p=0.529), Karnofsky status (p=0.539), depression (p= 0.095), confusion (p=0.074), possible causes of awaking (p= 0.881), use of opioids (p= 0.798), use of hypnotics (p= 0.197), other morbidities (p=0.460), or use of alcohol or coffee (p= 0.141). Patients admitted for pain control and/or those receiving opioids more frequently had drowsiness (p=0.01) Patients with lower Karnofsky scores had more drowsiness and diurnal hours slept (p=0.01). Anxiety created more difficulties in falling asleep, produced a less restoring sleep, and nightmares. Depression was associated with early awaking, nonrestorative sleep, fatigue, and nightmares. Confusion was associated with fatigue and nightmares.

Conclusion

Sleep problems appear to be a significant issue for advanced cancer patients. Attention to sleep disturbance needs to be incorporated into the routine practice in palliative care evaluation.
Literature
1.
go back to reference Affleck G, Urrows S, Tennen H, et al (1996) Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromialgia. Pain 68:363–368CrossRefPubMed Affleck G, Urrows S, Tennen H, et al (1996) Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromialgia. Pain 68:363–368CrossRefPubMed
2.
go back to reference Ancoli-Israel S, Moore PJ, Jones V (2001) The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 10:245–255CrossRef Ancoli-Israel S, Moore PJ, Jones V (2001) The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 10:245–255CrossRef
3.
go back to reference Anderson K, Getto G, Mendoza T, Palmer S, Wang XS, ReyesGibby C, Cleeland C (2003) Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage 25:307–318CrossRefPubMed Anderson K, Getto G, Mendoza T, Palmer S, Wang XS, ReyesGibby C, Cleeland C (2003) Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage 25:307–318CrossRefPubMed
4.
go back to reference Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A (2004) Psychometric evaluation of the Pittsburgh sleep quality index in cancer patients. J Pain Symptom Manage 27:140–148CrossRef Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A (2004) Psychometric evaluation of the Pittsburgh sleep quality index in cancer patients. J Pain Symptom Manage 27:140–148CrossRef
5.
go back to reference Carpenter JS, Andrykowski MA (1998) Psychometric evaluation of the Pittsburgh Sleep quality index. J Psychosom Res 45:5–13 Carpenter JS, Andrykowski MA (1998) Psychometric evaluation of the Pittsburgh Sleep quality index. J Psychosom Res 45:5–13
6.
go back to reference Davidson JR, MacLean AW, Brudage MD, Schulze K (2002) Sleep disturbances in cancer patients. Soc Sci Med 54:1309–1321CrossRefPubMed Davidson JR, MacLean AW, Brudage MD, Schulze K (2002) Sleep disturbances in cancer patients. Soc Sci Med 54:1309–1321CrossRefPubMed
7.
go back to reference Ford DE, Kamerow DB (1989) Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 262:1479–1484CrossRefPubMed Ford DE, Kamerow DB (1989) Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 262:1479–1484CrossRefPubMed
8.
go back to reference Fortner B, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH (2002) Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 24:471–480CrossRefPubMed Fortner B, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH (2002) Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 24:471–480CrossRefPubMed
9.
go back to reference Ginsburg ML, Quirt C, Ginsburg AD et al (1995) Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer. Can Med Assoc J 152:701–709 Ginsburg ML, Quirt C, Ginsburg AD et al (1995) Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer. Can Med Assoc J 152:701–709
10.
go back to reference Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M (1993) Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 8:196–200PubMed Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M (1993) Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 8:196–200PubMed
11.
go back to reference Haponik EF, Frye AW, Richards B, et al (1996) Sleep history is neglected diagnostic information. Challenges for primary care physicians. J Gen Intern Med 11:759–761PubMed Haponik EF, Frye AW, Richards B, et al (1996) Sleep history is neglected diagnostic information. Challenges for primary care physicians. J Gen Intern Med 11:759–761PubMed
12.
go back to reference Koopman C, Nouriani B, Erickson V, et al (2002) Sleep disturbances in women with metastatic breast cancer. Breast J 8:362–370CrossRefPubMed Koopman C, Nouriani B, Erickson V, et al (2002) Sleep disturbances in women with metastatic breast cancer. Breast J 8:362–370CrossRefPubMed
13.
go back to reference Malone M, Harris AL, Luscombe DK (1994) Assessment of the impact of cancer on work, recreation, home, management and sleep using a general health status measure. J R Soc Med 87:386–389PubMed Malone M, Harris AL, Luscombe DK (1994) Assessment of the impact of cancer on work, recreation, home, management and sleep using a general health status measure. J R Soc Med 87:386–389PubMed
14.
go back to reference McCorcke R, Quintin-Benoliel J (1983) Symptom distress, current concerns and mood disturbances after diagnosis of life-threatening disease. Soc Sci Med 17:431–438CrossRefPubMed McCorcke R, Quintin-Benoliel J (1983) Symptom distress, current concerns and mood disturbances after diagnosis of life-threatening disease. Soc Sci Med 17:431–438CrossRefPubMed
15.
go back to reference Mercadante S. Casuccio A, Fulfaro F (2000) The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 20:246–252CrossRefPubMed Mercadante S. Casuccio A, Fulfaro F (2000) The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 20:246–252CrossRefPubMed
16.
go back to reference Miaskowski C, Lee KA (1999) Pain. Fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis. A pilot study. J Pain Symptom Manage 17:320–332PubMed Miaskowski C, Lee KA (1999) Pain. Fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis. A pilot study. J Pain Symptom Manage 17:320–332PubMed
17.
go back to reference Moore P, Dimsdale JE (2002) Opioids, sleep, and cancer-related fatigue. Med Hypothese 58:77–82CrossRef Moore P, Dimsdale JE (2002) Opioids, sleep, and cancer-related fatigue. Med Hypothese 58:77–82CrossRef
18.
go back to reference Morin CM, Gibson DG, Wade J (1998) Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 14:311–314CrossRefPubMed Morin CM, Gibson DG, Wade J (1998) Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 14:311–314CrossRefPubMed
19.
go back to reference Ng K, von Gunten CF (1998) Symptoms and attitudes of 100 consecutive patients admitted to an acute hospice/palliative care unit. J Pain Symptom Manage 16:307–316CrossRefPubMed Ng K, von Gunten CF (1998) Symptoms and attitudes of 100 consecutive patients admitted to an acute hospice/palliative care unit. J Pain Symptom Manage 16:307–316CrossRefPubMed
20.
go back to reference Portenoy RK, Miransky J, Thaler HT et al (1992) Pain in ambulatori patients with lung or colon cancer. Cancer 14:1616–1624 Portenoy RK, Miransky J, Thaler HT et al (1992) Pain in ambulatori patients with lung or colon cancer. Cancer 14:1616–1624
21.
go back to reference Portenoy RK, Thaler HT, Korblith AB, et al (1994) Symptom prevalence, characteristics, and distress in a cancer population. Qual Life Res 3:183–189PubMed Portenoy RK, Thaler HT, Korblith AB, et al (1994) Symptom prevalence, characteristics, and distress in a cancer population. Qual Life Res 3:183–189PubMed
22.
go back to reference Sanna P, Bruera E (2002) Insomnia and sleep disturbances. Eur J Palliat Care 9:8–12 Sanna P, Bruera E (2002) Insomnia and sleep disturbances. Eur J Palliat Care 9:8–12
23.
go back to reference Sarna L (1993) Correlates of symptom di stress in women with lung cancer. Cancer Practice 1:21–18PubMed Sarna L (1993) Correlates of symptom di stress in women with lung cancer. Cancer Practice 1:21–18PubMed
24.
go back to reference Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19:895–908PubMed Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19:895–908PubMed
25.
go back to reference Thomas C (1987) Insomnia among individual with cancer (abstract). Onc Nurs Soc 13:63 Thomas C (1987) Insomnia among individual with cancer (abstract). Onc Nurs Soc 13:63
26.
go back to reference Van der Pompe G, Antoni MH, Heijnen CJ (1996) Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 21:361–374CrossRefPubMed Van der Pompe G, Antoni MH, Heijnen CJ (1996) Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 21:361–374CrossRefPubMed
27.
go back to reference Van’t Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59:280–293PubMed Van’t Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59:280–293PubMed
Metadata
Title
Sleep disorders in advanced cancer patients: prevalence and factors associated
Authors
Sebastiano Mercadante
Davide Girelli
Alessandra Casuccio
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0623-4

Other articles of this Issue 5/2004

Supportive Care in Cancer 5/2004 Go to the issue

Forthcoming Meetings

May 2004

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine